Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04452695 · ClinicalTrials.gov registry record

Acceptability of Telehealth Triage Using Robotic Systems in COVID-19

A clinical trial, sponsored by Brigham and Women's Hospital.

Completed
Registry status
40
Enrollment target

NCT04452695: Completed study, sponsored by Brigham and Women's Hospital.

NCT04452695 is a clinical trial that has completed, run by Brigham and Women's Hospital. The registered enrollment target is 40 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04452695 has completed, sponsored by Brigham and Women's Hospital.

COMPLETED
Registry status
40 participants
Enrollment target

Study Summary

The overall objective of this investigation is to understand the patient response to a robotic platform used to facilitate telehealth triage in the emergency department during the COVID-19 pandemic. The COVID-19 pandemic has altered the manner in which emergency department triage is completed. Attempts at cohorting individuals with potential COVID-19 disease in order to prevent disease transmission to healthcare workers and minimize the use of personal protective equipment (PPE) have renewed interest in telemedical solutions as a method to triage and manage individuals with COVID-19. This investigation deploys a legged robotic platform to facilitate agile, highly mobile telemedicine to manage COVID-19 patients in the emergency department. The primary objective is to measure the patient response to interacting with these systems.

Primary Outcome

Quantitative questionnaire on the acceptance of virtual robotic care graded on a likert scale (higher scores better)

Interventions

  • DEVICE Doctor Spot

Trial Details

FieldValue
Enrollment Target 40 participants
Start Date 2020-03-10
Est. Completion 2020-08-10
Brigham and Women's Hospital

937 total trials

What the finished NCT04452695 record still lists

NCT04452695 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 40 participants, a relatively small participant target.

The record links to 0 conditions, and to 1 intervention - of which Doctor Spot is the first listed.

NCT04452695 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT04452695 about?

NCT04452695 is a clinical study titled "Acceptability of Telehealth Triage Using Robotic Systems in COVID-19". The overall objective of this investigation is to understand the patient response to a robotic platform used to facilitate telehealth triage in the emergency department during the COVID-19 pandemic. The COVID-19 pandemic has altered the manner in which emergency department triage is completed. Attem...

What is the current status of trial NCT04452695?

This trial is currently completed. The enrollment target is 40 participants. The study started on 2020-03-10. Estimated completion is 2020-08-10.

What interventions are being tested in trial NCT04452695?

The interventions under investigation include: Doctor Spot (DEVICE).

Who is sponsoring clinical trial NCT04452695?

This trial is sponsored by Brigham and Women's Hospital, which has 937 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01306019 · 40 participants · Phase 1

    Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)

  • NCT01608152 · 40 participants

    Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors

  • NCT01668082 · 40 participants · NA

    An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection

  • NCT02015013 · 40 participants · Phase 2

    Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04452695, the US trial registry maintained by the National Library of Medicine. NCT04452695 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.